PRINCETON, N.J., Feb. 14, 2013 /PRNewswire/ -- PeriGen, Inc., the global leader in applying real-time clinical decision support to perinatal systems, announced today that it has appointed Thomas J.Garite MD as Chief Clinical Officer, effective immediately.
A specialist in Obstetrics and Gynecology and Maternal-Fetal Medicine, in addition to his work with PeriGen and its clients, Thomas J. Garite, MD, holds three positions which include: Editor-In-Chief, American Journal of Obstetrics and Gynecology; Chairman, Society for Maternal-Fetal Medicine Foundation; Director of Research and Education for Obstetrix/Pediatrix Medical Group. Dr. Garite is the author or co-author of five textbooks and has published over 100 original journal articles and a similar number of abstracts, chapters and invited articles. He is a past president of the Society for Maternal-Fetal Medicine, as well as a twelve year member of its Board of Directors. He has also been a Member of the Board of Directors of the Division of Maternal Fetal Medicine of the American Board of Obstetrics and Gynecology, and Director of the Oral Examinations for this Board, as well as a Member of the Technical Bulletin and Course Coordination Committee of the American College of Obstetricians and Gynecologists. A recipient of the Career Achievement Award from the Society for Maternal-Fetal Medicine and the National Teaching Award from the Association of Professors of Obstetrics and Gynecology, Dr. Garite remains active in clinical research.
In his role with PeriGen, Dr. Garite will work with key perinatal thought leaders to further the research that fuels PeriGen technology to continue to positively impact the most pressing challenges facing obstetrics today. His perspective will touch multiple parts of the company's operations including product design and development.
PeriGen CEO Matthew Sappern said, "It is an honor for PeriGen to have Thomas Garite as part of our team. His research experience and leadership is invaluable to PeriGen's mission to build systems that usher in a new level of understanding of obstetrical safety, especially fetal surveillance."
About his new position as Chief Clinical Officer, Garite said, "Working with PeriGen represents an opportunity to merge a lifetime of clinical and research experience with software tools that have the potential to affect the next generation of clinicians, mothers and babies."
About PeriGen, Inc.
PeriGen. Inc., is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen's customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems.
PeriGen's unique fetal surveillance products provide dynamic visual cues that direct clinicians to the most essential patient information displayed on the screen. Unlike legacy fetal monitoring devices and software from non-specialist companies, PeriGen Visual Cueing™ provides an instant view of the mother's and baby's current status and trends over time to avoid errors, increasing patient safety and reducing risk for clinicians and hospitals. For more information, please visit us at www.PeriGen.com.
SOURCE PeriGen, Inc.